Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 6103457, 8 pages
http://dx.doi.org/10.1155/2016/6103457
Review Article

Decavanadate Toxicology and Pharmacological Activities: V10 or V1, Both or None?

1Faculty of Sciences and Technology, University of Algarve, Campus of Gambelas, 8005-135 Faro, Portugal
2CCMar (Centre of Marine Sciences), University of Algarve, Campus of Gambelas, 8005-135 Faro, Portugal

Received 26 September 2015; Accepted 24 December 2015

Academic Editor: Juan Llopis

Copyright © 2016 M. Aureliano. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Aureliano, “Recent perspectives into biochemistry of decavanadate,” World Journal of Biological Chemistry, vol. 2, no. 10, pp. 215–225, 2011. View at Publisher · View at Google Scholar
  2. S. Toumi, N. Ratel-Ramond, and S. Akriche, “Decavanadate cage-like cluster templated by organic counter cation: synthesis, characterization and its antimicrobial effect against Gram positive E. Feacium,” Journal of Cluster Science, vol. 26, no. 5, pp. 1821–1831, 2015. View at Publisher · View at Google Scholar
  3. M. Aureliano and C. A. Ohlin, “Decavanadate in vitro and in vivo effects: facts and opinions,” Journal of Inorganic Biochemistry, vol. 137, pp. 123–130, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Hayashi, “Hetero and lacunary polyoxovanadate chemistry: synthesis, reactivity and structural aspects,” Coordination Chemistry Reviews, vol. 255, no. 19-20, pp. 2270–2280, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Chen, S. Yan, H. Wang, Z. Hu, X. Wang, and M. Huo, “Aerobic oxidation of starch catalyzed by isopolyoxovanadate Na4Co(H2O)6V10O28,” Carbohydrate Polymers, vol. 117, pp. 673–680, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Mohapatra and K. M. Parida, “Dramatic activities of vanadate intercalated bismuth doped LDH for solar light photocatalysis,” Physical Chemistry Chemical Physics, vol. 16, no. 32, pp. 16985–16996, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Bijelic and A. Rompel, “The use of polyoxometalates in protein crystallography—an attempt to widen a well-known bottleneck,” Coordination Chemistry Reviews, vol. 299, pp. 22–38, 2015. View at Publisher · View at Google Scholar
  8. B. N. Chen, R. Xing, F. Wang, A. P. Zheng, and L. Wang, “Inhibitory effects of α-Na8SiW11CoO40 on tyrosinase and its application in controlling browning of fresh-cut apples,” Food Chemistry, vol. 188, pp. 177–183, 2015. View at Publisher · View at Google Scholar
  9. S. Yerra, B. K. Tripuramallu, and S. K. Das, “Decavanadate-based discrete compound and coordination polymer: synthesis, crystal structures, spectroscopy and nano-materials,” Polyhedron, vol. 81, pp. 147–153, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Borges, P. Mendonça, N. Joaquim, J. M. Coucelo, and M. Aureliano, “Acute effects of vanadate oligomers on heart, kidney, and liver histology in the Lusitanian toadfish (Halobatrachus didactylus),” Archives of Environmental Contamination and Toxicology, vol. 45, no. 3, pp. 415–422, 2003. View at Google Scholar
  11. G. R. Willsky, D. A. White, and B. C. McCabe, “Metabolism of added orthovanadate to vanadyl and high-molecular-weight vanadates by Saccharomyces cerevisiae,” The Journal of Biological Chemistry, vol. 259, no. 21, pp. 13273–13281, 1984. View at Google Scholar · View at Scopus
  12. G. Fraqueza, C. A. Ohlin, W. H. Casey, and M. Aureliano, “Sarcoplasmic reticulum calcium ATPase interactions with decaniobate, decavanadate, vanadate, tungstate and molybdate,” Journal of Inorganic Biochemistry, vol. 107, no. 1, pp. 82–89, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Ramos, M. Manuel, T. Tiago et al., “Decavanadate interactions with actin: inhibition of G-actin polymerization and stabilization of decameric vanadate,” Journal of Inorganic Biochemistry, vol. 100, no. 11, pp. 1734–1743, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Pereira, E. Carvalho, J. W. Eriksson, D. C. Crans, and M. Aureliano, “Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes,” Journal of Inorganic Biochemistry, vol. 103, no. 12, pp. 1687–1692, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Galani, V. Tsitsias, D. Stellas, V. Psycharis, C. P. Raptopoulou, and A. Karaliota, “Two novel compounds of vanadium and molybdenum with carnitine exhibiting potential pharmacological use,” Journal of Inorganic Biochemistry, vol. 142, pp. 109–117, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Kioseoglou, C. Gabriel, S. Petanidis et al., “Binary decavanadate-betaine composite materials of potential anticarcinogenic activity,” Zeitschrift fur Anorganische und Allgemeine Chemie, vol. 639, no. 8-9, pp. 1407–1416, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Douglas and M. Young, “Host–guest encapsulation of materials by assembled virus protein cages,” Nature, vol. 393, no. 6681, pp. 152–155, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Legrum, “The mode of reduction of vanadate(+V) to oxovanadium (+IV) by glutathione and cysteine,” Toxicology, vol. 42, no. 2-3, pp. 281–289, 1986. View at Publisher · View at Google Scholar · View at Scopus
  19. L. S. Capella, M. R. Gefé, E. F. Silva et al., “Mechanisms of vanadate-induced cellular toxicity: role of cellular glutathione and NADPH,” Archives of Biochemistry and Biophysics, vol. 406, no. 1, pp. 65–72, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Zhang, S. S. Leonard, C. Huang, V. Vallyathan, V. Castranova, and X. Shi, “Role of reactive oxygen species and MAPKs in vanadate-induced G(2)/M phase arrest,” Free Radical Biology and Medicine, vol. 34, no. 10, pp. 1333–1342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Chakrabarty and R. Banerjee, “Kinetics and mechanism of oxidation of 2-mercaptoethanol by the heteropolyoxovanadate [MnV13O38]7−,” International Journal of Chemical Kinetics, vol. 47, no. 1, pp. 13–18, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. S. J. Stohs and D. Bagchi, “Oxidative mechanisms in the toxicity of metal ions,” Free Radical Biology and Medicine, vol. 18, no. 2, pp. 321–336, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Z. Byczkowski and A. P. Kulkarni, “Oxidative stress and pro-oxidant biological effects of vanadium,” in Vanadium in the Environment, Part 1: Chemistry and Biochemistry, J. O. Nriagu, Ed., pp. 235–263, John Wiley & Sons, New York, NY, USA, 1998. View at Google Scholar
  24. L. Colin-Barenque, J. Pedraza-Chaverri, O. Medina-Campos et al., “Functional and morphological olfactory bulb modifications in mice after vanadium inhalation,” Toxicologic Pathology, vol. 43, no. 2, pp. 282–291, 2015. View at Publisher · View at Google Scholar
  25. J. Edel and E. Sabbioni, “Accumulation, distribution and form of vanadate in the tissues and organelles of the mussel Mytilus edulis and the goldfish Carassius auratus,” Science of the Total Environment, vol. 133, no. 1-2, pp. 139–151, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. W. M. Bracken, R. P. Sharma, and Y. Y. Elsner, “Vanadium accumulation and subcellular distribution in relation to vanadate induced cytotoxicity in vitro,” Cell Biology and Toxicology, vol. 1, no. 4, pp. 259–268, 1985. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Zhao, L. Ye, H. Liu et al., “Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress,” Journal of Inorganic Biochemistry, vol. 104, no. 4, pp. 371–378, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. S. Soares, C. Gutiérrez-Merino, and M. Aureliano, “Mitochondria as a target for decavanadate toxicity in Sparus aurata heart,” Aquatic Toxicology, vol. 83, no. 1, pp. 1–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. S. S. Soares, F. Henao, M. Aureliano, and C. Gutiérrez-Merino, “Vanadate induces necrotic death in neonatal rat cardiomyocytes through mitochondrial membrane depolarization,” Chemical Research in Toxicology, vol. 21, no. 3, pp. 607–618, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Ramasarma and A. V. S. Rao, “Decavanadate interacts with microsomal NADH oxidation system and enhances cytochrome c reduction,” Molecular and Cellular Biochemistry, vol. 281, no. 1-2, pp. 139–144, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. A. V. S. Rao and T. Ramasarma, “NADH-dependent decavanadate reductase, an alternative activity of NADP-specific isocitrate dehydrogenase protein,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 1474, no. 3, pp. 321–330, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. S. K. Ghosh, R. Saha, and B. Saha, “Toxicity of inorganic vanadium compounds,” Research on Chemical Intermediates, vol. 41, no. 7, pp. 4873–4897, 2015. View at Publisher · View at Google Scholar
  33. L. S. Capella, J. S. M. Alcantara, V. Moura-Neto, A. G. Lopes, and M. A. M. Capella, “Vanadate is toxic to adherent-growing multidrug-resistant cells,” Tumor Biology, vol. 21, no. 1, pp. 54–62, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. S. B. Etcheverry and A. N. Cortizo, “Bioactivity of vanadium compounds on cells in culture,” in Vanadium in the Environment, Part 1: Chemistry and Biochemistry, J. O. Nriagu, Ed., pp. 359–395, John Wiley & Sons, New York, NY, USA, 1998. View at Google Scholar
  35. C. M. O'Reilly, K. E. Fogarty, R. M. Drummond, R. A. Tuft, and J. V. Walsh Jr., “Spontaneous mitochondrial depolarizations are independent of SR Ca2+ release,” American Journal of Physiology—Cell Physiology, vol. 286, no. 5, pp. C1139–C1151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. B. J. Poindexter, J. R. Smith, L. M. Buja, and R. J. Bick, “Calcium signalling mechanisms in dedifferentiated cardiac myocytes: comparison with neonatal and adult cardiomyocytes,” Cell Calcium, vol. 30, pp. 373–382, 2001. View at Google Scholar
  37. L. Sandirasegarane and V. Gopalakrishnan, “Vanadate increases cytosolic free calcium in rat aortic smooth muscle cells,” Life Sciences, vol. 56, no. 7, pp. PL169–PL174, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Braunwald, “Vanadate increases cytosolic free calcium in rat aortic smooth muscle cells,” Cardioscience, vol. 5, pp. 139–144, 1994. View at Google Scholar
  39. P. Caroni and E. Carafoli, “The Ca2+-pumping ATPase of heart sarcolemma. Characterization, calmodulin dependence, and partial purification,” Journal of Biological Chemistry, vol. 256, no. 7, pp. 3263–3270, 1981. View at Google Scholar · View at Scopus
  40. L. Dux and A. Martonosi, “Two-dimensional arrays of protein in sarcoplasmic reticulum and purified Ca2+-ATPase vesicles treated with vanadate,” The Journal of Biological Chemistry, vol. 258, no. 4, pp. 2599–2603, 1983. View at Google Scholar · View at Scopus
  41. M. Aureliano and V. M. C. Madeira, “Interactions of vanadate oligomers with sarcoplasmic reticulum Ca2+-ATPase,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1221, no. 3, pp. 259–271, 1994. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Fraqueza, L. A. E. Batista de Carvalho, M. P. M. Marques et al., “Decavanadate, decaniobate, tungstate and molybdate interactions with sarcoplasmic reticulum Ca2+-ATPase: quercetin prevents cysteine oxidation by vanadate but does not reverse ATPase inhibition,” Dalton Transactions, vol. 41, no. 41, pp. 12749–12758, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Hua, G. Inesi, and C. Toyoshima, “Distinct topologies of mono- and decavanadate binding and photo-oxidative cleavage in the sarcoplasmic reticulum ATPase,” The Journal of Biological Chemistry, vol. 275, no. 39, pp. 30546–30550, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. J. P. Fawcett, S. J. Farquhar, R. J. Walker, T. Thou, G. Lowe, and A. Goulding, “The effect of oral vanadyl sulphate on body composition and performance in weight-training athletes,” International Journal of Sport Nutrition, vol. 6, pp. 382–390, 1996. View at Google Scholar
  45. L. Josephson and L. C. Cantley Jr., “Isolation of a potent (Na-K)ATPase inhibitor from striated muscle,” Biochemistry, vol. 16, no. 21, pp. 4572–4578, 1977. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Gruzewska, A. Michno, T. Pawelczyk, and H. Bielarczyk, “Essentiality and toxicity of vanadium supplements in health and pathology,” Journal of Physiology and Pharmacology, vol. 65, no. 5, pp. 603–611, 2014. View at Google Scholar · View at Scopus
  47. A. Månsson, D. Rassier, and G. Tsiavaliaris, “Poorly understood aspects of striated muscle contraction,” BioMed Research International, vol. 2015, Article ID 245154, 28 pages, 2015. View at Publisher · View at Google Scholar
  48. C. C. Goodno, “Inhibition of myosin ATPase by vanadate ion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 6, pp. 2620–2624, 1979. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Tiago, M. Aureliano, and C. Gutiérrez-Merino, “Decavanadate binding to a high affinity site near the myosin catalytic centre inhibits F-actin-stimulated myosin ATPase activity,” Biochemistry, vol. 43, no. 18, pp. 5551–5561, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Ramos, R. O. Duarte, J. J. G. Moura, and M. Aureliano, “Decavanadate interactions with actin: cysteine oxidation and vanadyl formation,” Dalton Transactions, no. 38, pp. 7985–7994, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Rodriguez-Lara, A. Morales-Rivero, A. M. Rivera-Cambas, and T. I. Fortoul, “Vanadium inhalation induces actin changes in mice testicular cells,” Toxicology and Industrial Health, pp. 1–8, 2013. View at Publisher · View at Google Scholar
  52. D. G. Barceloux, “Vanadium,” Journal of Toxicology: Clinical Toxicology, vol. 37, no. 2, pp. 265–278, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. T. L. Turner, V. H. Nguyen, C. C. McLauchlan et al., “Inhibitory effects of decavanadate on several enzymes and Leishmania tarentolae in vitro,” Journal of Inorganic Biochemistry, vol. 108, pp. 96–104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Yraola, S. Garcia-Vicente, L. Marti, F. Albericio, A. Zorzano, and M. Royo, “Understanding the mechanism of action of the novel SSAO substrate (C7NH10)6(V10O28)·2H2O, a prodrug of peroxovanadate insulin mimetics,” Chemical Biology and Drug Design, vol. 69, no. 6, pp. 423–428, 2007. View at Publisher · View at Google Scholar
  55. J. T. Rhule, C. L. Hill, D. A. Judd, and R. F. Schinazi, “Polyoxometalates in medicine,” Chemical Reviews, vol. 98, no. 1, pp. 327–357, 1998. View at Publisher · View at Google Scholar · View at Scopus
  56. T. Yamase, “Anti-tumor, -viral, and -bacterial activities of polyoxometalates for realizing an inorganic drug,” Journal of Materials Chemistry, vol. 15, no. 45, pp. 4773–4782, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. Y.-T. Li, C.-Y. Zhu, Z.-Y. Wu, M. Jiang, and C.-W. Yan, “Synthesis, crystal structures and anticancer activities of two decavanadate compounds,” Transition Metal Chemistry, vol. 35, no. 5, pp. 597–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. F. Zhai, X. Wang, D. Li, H. Zhang, R. Li, and L. Song, “Synthesis and biological evaluation of decavanadate Na4Co(H2O)6V10O28·18H2O,” Biomedicine & Pharmacotherapy, vol. 63, no. 1, pp. 51–55, 2009. View at Publisher · View at Google Scholar
  59. R. Raza, A. Matin, S. Sarwar et al., “Polyoxometalates as potent and selective inhibitors of alkaline phosphatases with profound anticancer and amoebicidal activities,” Dalton Transactions, vol. 41, no. 47, pp. 14329–14336, 2012. View at Publisher · View at Google Scholar · View at Scopus